Vaccine-Related Journal Articles
Diseases and Vaccines
Anthrax Measles Rabies
Diphtheria Meningococcus Rotavirus
Hepatitis A Mumps Rubella
Hepatitis B

Pertussis

Smallpox
Hib PCV7 Tetanus
HPV PPV23 Varicella
Influenza Polio Zoster
Pneumococcal conjugate vaccine (PCV7) 2003 Recent PCV7 articles
Recurrent Invasive Pneumococcal Disease: A Population-Based Assessment
Authors: King MD, Whitney CG, Parekh F, et al
Source: Clin Infect Dis, October 15, 2003, Vol 37(8):1029-1036. Epub 2003 Sep 24
Abstract
How Many Episodes of Hospital Care Might Be Prevented by Widespread Uptake of Pneumococcal Conjugate Vaccine?
Author: McIntosh ED
Source: Arch Dis Child, October 2003, Vol. 88(10):859-861
Abstract
The Safety, Reactogenicity and Immunogenicity of a 7-Valent Pneumococcal Conjugate Vaccine (7VPnC) Concurrently Administered with a Combination DTaP-IPV-Hib Vaccine
Authors: Schmitt HJ, Faber J, Lorenz I, Schmole-Thoma B, Ahlers N
Source: Source: Vaccine, September 8, 2003, Vol. 21(25-26):3653-62
Abstract
Benefits and Costs of Immunization of Children with Pneumococcal Conjugate Vaccine in Canada
Authors: De Wals P, Petit G, Erickson LJ, et al
Source: Vaccine, Sept. 8, 2003, Vol. 21(25-26):3757-3764
Abstract
Influence of Insurance Status and Vaccine Cost on Physicians' Administration of Pneumococcal Conjugate Vaccine
Authors: Davis MM, Ndiaye SM, Freed GL, et al
Source: Pediatrics, September 2003, Vol. 112(3 Pt 1):521-526
Abstract
Efficacy and Safety of Seven-valent Conjugate Pneumococcal Vaccine in American Indian Children: Group Randomised Trial
Authors: O'Brien KL, Moulton LH, Reid R, et al
Source: Lancet, August 2, 2003, Vol. 362(9381):355-361
Abstract
Changes in Treatment Strategies for Acute Otitis Media After Full Implementation of the Pneumococcal Seven Valent Conjugate Vaccine
Author: Harrison CJ
Source: Pediatr Infect Dis J, August 2003, Vol. 22(8 Suppl):S120-30
Abstract
Cost-Effectiveness of a Pneumococcal Conjugate Immunisation Program for Infants in Switzerland
Authors: Ess SM, Schaad UB, Gervaix A, et al
Source: Vaccine, July 4, 2003, Vol. 21(23):3273-3281
Abstract
Review of Randomized Controlled Trials on Pneumococcal Vaccination for Prevention of Otitis Media
Authors: Straetemans M, Sanders EAM, Veenhoven RH, et al
Source: Pediatr Infect Dis J, June 2003, Vol. 22(6):515-524
Abstract
Vaccination of Day-Care Center Attendees Reduces Carriage of Streptococcus pneumoniae Among Their Younger Siblings
Authors: Givon-Lavi N, Fraser D, Dagan R
Source: Pediatr Infect Dis J, June 2003, Vol. 22(6):524-531
Abstract
Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants
Authors: Zangwill KM, Greenberg DP, Chiu CY, et al
Source: Vaccine, May 16, 2003, Vol. 21(17-18):1894-1900
Abstract
Pediarix--A Combined Vaccine for Infants
Source: The Medical Letter, May 12, 2003, Vol. 45(1156):37-38
Abstract not available. Subscription only.
HTML
Decline in Invasive Pneumococcal Disease after the Introduction of Protein-Polysaccharide Conjugate Vaccine
Authors: Whitney CG, Farley MM, Hadler J, et al
Source: The New England Journal of Medicine, May 1, 2003, Vol. 348(18):1737-1746
Abstract
Streptococcus pneumoniae-related Illnesses in Young Children: Secular Trends and Regional Variation
Authors: Poehling KA, Szilagyi PG, Edwards K, et al
Source: The Pediatric Infectious Disease Journal, May 2003, Vol. 22(5):413-418
Abstract
Pneumococcal Conjugate Vaccines: Proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy
Authors: Pelton SI, Dagan R, Gaines BM, et al
Source: Vaccine, April 2, 2003, Vol. 21(15):1562-1571
Abstract
Incidence of Invasive Pneumococcal Disease in Children 3 to 36 Months of Age at a Tertiary Care Pediatric Center 2 Years After Licensure of the Pneumococcal Conjugate Vaccine
Authors: Lin PL, Michaels MG, Janosky J, et al
Source: Pediatrics, April 2003, Vol. 111(4):896-899
N/A
Pneumococcal Vaccine (Prevnar) for Otitis Media
Author: Anonymous
Source: Medical Letter on Drugs & Therapeutics, March 31, 2003, Vol. 45(1153):27-28
N/A
Variation in Public and Private Supply of Pneumococcal Conjugate Vaccine During a Shortage
Authors: Freed GL, Davis MM, Clark SJ
Source: JAMA, February 5, 2003, Vol. 289(5):575-578
Abstract
Impact of the Pneumococcal Conjugate Vaccine on Otitis Media
Authors: Fireman B, Black SB, Shinefield HR, et al
Source: Pediatr Infect Dis J, January 2003, Vol. 22(1):10-16
Abstract
Pneumococcal conjugate vaccine (PCV7) 2002 back to top
Physician Perspectives Regarding Pneumococcal Conjugate Vaccine
Authors: Schaffer SJ, Szilagyi PG, Shone LP
Source: Pediatrics, December 2002, Vol. 110(6):e68
Abstract
Notice to Readers: Pneumococcal Vaccination for Cochlear Implant Recipients
Source: MMWR, October 18, 2002, Vol. 51(41):931
HTML
The New Pneumococcal Vaccine
Author: Obaro SK
Source: Clinical Microbiology and Infection, October 2002, Vol. 8(10):623-633
Abstract
The Potential of Pneumococcal Conjugate Vaccines for Children: Centers for Disease Control and Prevention: Current Issues in Pediatrics
Authors: Whitney CG
Source: The Pediatric Infectious Disease Journal, October 2002, Vol. 21(10):961-970
Abstract
The Future of Pneumococcal Conjugate Vaccines for Prevention of Pneumococcal Diseases in Infants and Children
Authors: Pelton SI, Klein JO
Source: Pediatrics, October 2002, Vol. 110(4):805-814
Abstract
Pediatricians' Views on Financial Barriers and Values for Pneumococcal Vaccine for Children
Authors: Lieu TA, Finkelstein JA, Adams, MM, et al
Source: Ambulatory Pediatrics, September-October 2002, Vol. 2(5):358-66
Abstract
Effectiveness of Heptavalent Pneumococcal Conjugate Vaccine in Children Younger than Five Years of Age for Prevention of Pneumonia
Authors: Black SB, Shinefield HR, Ling S, et al
Source: The Pediatric Infectious Disease Journal, September 2002, Vol. 21(9):810-816
Abstract
Reimbursement for Prevnar: A Modern-Day Version of Hercules and the Hydra
Authors: Freed GL, Davis MM, Andreae MC, Bass S, Weinblatt H
Source: Pediatrics, August 2002, Vol. 110(2):399-400
(Available online for subscribers only)
N/A
The Pneumococcal Conjugate Vaccine
Authors: Jacobson RM, Poland GA
Source: Minerva Pediatrica, August 2002, Vol. 54(4):295-303
Abstract
Pneumococcal Vaccination of Children
Author: Overturf GD
Source: Seminars in Pediatric Infectious Diseases, July 2002, Vol. 13(3):155-64
Abstract
Clinical Characteristics of Children with Complicated Pneumonia Caused by Streptococcus pneumoniae
Authors: Tan TQ, Mason EO, Wald ER, et al
Source: Pediatrics, July 2002, Vol. 110(1):1-6
Abstract
Efficacy, Immunogenicity and Safety of Heptavalent Pneumococcal Conjugate Vaccine in Low Birth Weight and Preterm Infants
Authors: Shinefield H, Black S, Ray P, Fineman B, Schwalbe J, Lewis E
Source: Pediatric Infectious Disease Journal, March 2002, Vol. 21:182-186
Abstract
Multidrug-resistant Streptococcus pneumoniae in a Child Care Center ---Southwest Georgia, December 2000
Authors: Centers for Disease Control and Prevention
Source: MMWR, January 4, 2002, Vol. 50(51):1156-8
HTML
Pneumococcal Vaccines for Infants and Children--Past, Present, and Future
Author: Klein JO
Source: Curr Clin Top Infect Dis, 2002, Vol. 22:252-265
Subscription only
N/A
Pneumococcal conjugate vaccine (PCV7) 2001 back to top
Postlicensure Evaluation of the Effectiveness of Seven Valent Pneumococcal Conjugate Vaccine
Authors: Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F
Source: Pediatric Infectious Disease Journal, December 2001, Vol. 20(12):1105-7
Abstract
Randomized Trial of the Quantitative and Functional Antibody Responses to a 7-Valent Pneumococcal Conjugate Vaccine and/or 23-Valent Polysaccharide Vaccine Among HIV-Infected Adults
Authors: Feikin DR, Elie CM, Goetz MB, et al.
Source: Vaccine, November 12, 2001, Vol. 20(3-4):545-53
Abstract
Effect of a Conjugate Pneumococcal Vaccine on the Occurrence of Respiratory Infections and Antibiotic Use in Day-care Center Attendees
Authors: Dagan R, Sikuler-Cohen M, Zamir O, Janco J, Givon-Lavi N, Fraser D
Source: Pediatric Infectious Disease Journal, October 2001 Vol. 20(10):951-8
Abstract
An Update on the New Pneumococcal Conjugate Vaccine
Author: Holland MJ
Source: Pediatric Annals, September 2001, Vol. 30(9):515-6
Abstract
Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998: Opportunities for Prevention in the Conjugate Vaccine Era
Author: Robinson KA, Baughman W, Rothrock G
Source: JAMA, April 4, 2001, Vol. 285(13):1729-35
Abstract
The Prevention of Pneumococcal Disease by Vaccines: Promises and Challenges
Author: Poland GA
Source: Infectious Disease Clinics of North America, March 2001, Vol. 15(1):97-122
Abstract
Efficacy of a Pneumococcal Conjugate Vaccine Against Acute Otitis Media
Authors: Eskola J, Kilpi T, Palmu A, et al.
Source: New England Journal of Medicine, February 8, 2001, Vol. 344(6):403-9
HTML
Pneumococcal conjugate vaccine (PCV7) 2000-1992 back to top
Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM(197) Among Infants with Sickle Cell Disease. Pneumococcal Conjugate Vaccine Study Group
Authors: O'Brien KL, Swift AJ, Winkelstein JA, et al.
Source: Pediatrics, November 2000, Vol. 106(5):965-72
Abstract
Preventing Pneumococcal Disease Among Infants and Young Children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, October 6, 2000, Vol. 49(RR-9):1-35
HTML
Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis
Authors: American Academy of Pediatrics, Committee on Infectious Diseases
Source: Pediatrics, August 2000, Vol. 106(2 Pt 1):367-76
Abstract
Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Apache and Navajo Indian, Alaska Native, and Non-Native American Children Aged <2 Years
Authors: Miernyk KM, Parkinson AJ, Rudolph KM, et al.
Source: Clinical Infectious Diseases, July 2000, Vol. 31(1):34-41
HTML
Efficacy of Pneumococcal Conjugate Vaccines in Large Scale Field Trials
Authors: Shinefield HR, Black S
Source: Pediatric Infectious Disease Journal, April 2000, Vol. 19(4):394-7
Abstract
Immunogenicity of Pneumococcal Conjugate Vaccines
Author: Eskola J
Source: Pediatric Infectious Disease Journal, April 2000, Vol. 19(4):388-93
Abstract
Pneumococcal Conjugate Vaccines
Author: Watson W
Source: Pediatric Infectious Disease Journal, April 2000, Vol. 19(4): 331-2
Abstract
A Pneumococcal Conjugate Vaccine for Infants and Children
Source: The Medical Letter on Drugs and Therapeutics, March 20, 2000, Vol. 42(1074):25-7
Abstract
Efficacy, Safety and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Children. Northern California Kaiser Permanente Vaccine Study Center Group
Authors: Black S, Shinefield H, Fireman B, et al.
Source: Pediatric Infectious Disease Journal, March 2000, Vol. 19(3):187-95
Abstract
Pneumococcal Conjugate Vaccination for Adults: Why it's Important for Children
Author: Fedson DS
Source: Pediatric Infectious Disease Journal, March 2000, Vol. 19(3):183-6
Abstract
Projected Cost-effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young Children
Author: Lieu TA, Ray GT, Black SB, et al.
Source: JAMA, March 15 2000, Vol. 283(11):1460-8
Abstract
Mortality from Invasive Pneumococcal Pneumonia in the Era of Antibiotic Resistance, 1995-1997
Authors: Feiken DR, Schuchat A, Kolczak M, et al.
Source: American Journal of Public Health, Infectious Diseases, February 2000, Vol. 90(2):223-9
Abstract
Safety and Immunogenicity of Heptavalent Pneumococcal CRM197 Conjugate Vaccine in Infants and Toddlers
Authors: Shinefield HR, Black S, Ray P, et al.
Source: Pediatric Infectious Disease Journal, September 1999, Vol. 18(9):757-63
Abstract
Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants
Authors: Rennels MB, Edwards KM, Keyserling HL
Source: Pediatrics, April 1998, Vol. 101(4):604-611
Abstract
Pneumococcal conjugate vaccine (PCV7) Articles back to top
PCV7 journal articles 2007-2004

Immunization Action Coalition  |  1573 Selby Avenue  |  St. Paul MN 55104
contact: admin@immunize.org  |  www.immunize.org
tel: 651.647.9009  |  fax: 651.647.9131